Y39-10557-90416
4 vaccinations
1 coded response
38 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-07-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4EQ-22933-73354
Child or adolescent in my care · Female · 2022-07-05
Timeline
-
2021-07-05
Registered in v-safe
-
2021-07-05
Dose 1 — Pfizer-BioNTech
- 2021-07-05
- 2021-07-06
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-19
-
2021-07-26
Dose 2 — Pfizer-BioNTech
- 2021-07-26
-
2021-07-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-07-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-07-29
-
2021-07-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-09
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-10-25
-
2022-01-06
Dose 3 — Pfizer-BioNTech
- 2022-01-24
- 2022-07-07
-
2022-10-06
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-08
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-15
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-18
-
2023-01-05
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-05 | Pfizer-BioNTech | No |
| 2 | 2021-07-26 | Pfizer-BioNTech | No |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
| 4 | 2022-10-06 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release